tradingkey.logo

Artivion Inc

AORT
查看详细走势图
46.600USD
-0.550-1.17%
收盘 12/19, 16:00美东报价延迟15分钟
2.21B总市值
亏损市盈率 TTM

Artivion Inc

46.600
-0.550-1.17%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.17%

5天

+3.28%

1月

+4.41%

6月

+56.90%

今年开始到现在

+62.99%

1年

+66.61%

查看详细走势图

TradingKey Artivion Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Artivion Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名2/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价51.71。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Artivion Inc评分

相关信息

行业排名
2 / 208
全市场排名
29 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 7 位分析师
买入
评级
51.714
目标均价
+17.35%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Artivion Inc亮点

亮点风险
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
业绩高增长
公司营业收入稳步增长,连续3年增长23.82%
估值低估
公司最新PE估值-201.94,处于3年历史低位
机构加仓
最新机构持股43.29M股,环比增加0.07%
乔尔·格林布拉特持仓
明星投资者乔尔·格林布拉特持仓,最新持仓市值14.72K
活跃度增加
近期活跃度增加,过去20天平均换手率0.99

Artivion Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Artivion Inc简介

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
公司代码AORT
公司Artivion Inc
CEOMackin (James Patrick)
网址https://artivion.com/

常见问题

Artivion Inc(AORT)的当前股价是多少?

Artivion Inc(AORT)的当前股价是 46.600。

Artivion Inc的股票代码是什么?

Artivion Inc的股票代码是AORT。

Artivion Inc股票的52周最高点是多少?

Artivion Inc股票的52周最高点是48.250。

Artivion Inc股票的52周最低点是多少?

Artivion Inc股票的52周最低点是21.970。

Artivion Inc的市值是多少?

Artivion Inc的市值是2.21B。

Artivion Inc的净利润是多少?

Artivion Inc的净利润为-13.34M。

现在Artivion Inc(AORT)的股票是买入、持有还是卖出?

根据分析师评级,Artivion Inc(AORT)的总体评级为买入,目标价格为51.714。

Artivion Inc(AORT)股票的每股收益(EPS TTM)是多少

Artivion Inc(AORT)股票的每股收益(EPS TTM)是-0.231。
KeyAI